Pathogenesis of TSC in the Brain

Tuberous Sclerosis Complex: Genes, Clinical Features and Therapeutics

Volumn , Issue , 2010, Pages 159-185

  Crino, Peter B ^a   Mehta, Rupal ^b   Vinters, Harry V ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Giant cell; SEGAs; Subependymal nodule; Tuber; Tuberous sclerosis complex; Ventricular zone

Indexed keywords

EID: 84886204445     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527630073.ch9     Document Type: Chapter

References (53)

1. Crino, P.B., Nathanson, K.L., and Henske, E.P. (2006) The tuberous sclerosis complex. N. Engl. J. Med., 355, 1345-1356.
2. Park, S.H., Pepkowitz, S.H., Kerfoot, C., De Rosa, M.J., Poukens, V., Wienecke, R., DeClue, J.E., and Vinters, H.V. (1997) Tuberous sclerosis in a 20-week gestationfetus: immunohistochemical study. Acta Neuropathol., 94, 180-186.
3. Levine, D., Barnes, P., Korf, B., and Edelman, R. (2000) Tuberous sclerosis in the fetus: second-trimester diagnosis of subependymal tubers with ultrafast MR imaging. AJR Am. J. Roentgenol., 175, 1067-1069.
4. Wortmann, S.B., Reimer, A., Creemers, J.W., and Mullaart, R.A. (2008) Prenatal diagnosis of cerebral lesions in tuberous sclerosis complex (TSC). Case report and review of the literature. Eur. J. Paediatr. Neurol., 12, 123-126.
5. Rott, H.D., Lemcke, B., Zenker, M., Huk, W., Horst, J., and Mayer, K. (2002) Cyst-like cerebral lesions in tuberous sclerosis. Am. J. Med. Genet., 111, 435-439.
6. Jurkiewicz, E., Jozwiak, S., Bekiesinska-Figatowska, M., Pakula-Kosciesza, I., and Walecki, J. (2006) Cyst-like cortical tubers in patients with tuberous sclerosis complex: MR imaging with the FLAIR sequence. Pediatr. Radiol., 36, 498-501.
7. Scheithauer, B.W. and Regan, T.J. (1999) Neuropathology, in Tuberous Sclerosis Complex (eds M.R. Gomez, J.R. Sampson, and V.H. Whittemore), Oxford University press, New York.
8. Maldonado, M., Baybis, M., Newman, D., Kolson, D.L., Chen, W., McKhann, G., 2nd, Gutmann, D.H., and Crino, P.B. (2003) Expression of ICAM-1, TNF-alpha, NF kappa B, and MAP kinase in tubers of the tuberous sclerosis complex. Neurobiol. Dis., 14, 279-290.
9. Boer, K., Jansen, F., Nellist, M., Redeker, S., van den Ouweland, A.M., Spliet, W.G., van Nieuwenhuizen, O., Troost, D. et al. (2008) Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Epilepsy Res., 78, 7-21.
10. Vinters, H.V. and Miyata, H. (2006) Neuropathologic features of tuberous sclerosis, in Russell and Rubinstein's Pathology of Tumors of the Nervous System, 7th edn (eds R.E. McLendon, M.K. Rosenblum, and D.D. Bigner), Hodder Arnold, London, UK, pp. 955-969.
11. Sosunov, A.A., Wu, X., Weiner, H.L., Mikell, C.B., Goodman, R.R., Crino, P.B., and McKhann, G.M., 2nd (2008) Tuberous sclerosis: a primary pathology of astrocytes? Epilepsia, 49 (Suppl. 2), 53-62.
12. Arai, Y., Takashima, S., and Becker, L.E. (2000) CD44 expression in tuberous sclerosis. Pathobiology., 68, 87-92.
13. White, R., Hua, Y., Lynch, D.R., Scheitauer, B., and Crino, P.B. (2002) Differential transcription of neurotransmitter receptor subunits and uptake sites in giant cells and dysplastic neurons in cortical tubers. Ann. Neurol., 49, 67-78.
14. Mizuguchi, M. and Takashima, S. (2001) Neuropathology of tuberous sclerosis. Brain Dev., 23, 508-515.
15. Mizuguchi, M. (2007) Abnormal giant cells in the cerebral lesions of tuberous sclerosis complex. Congenit.. Anom. (Kyoto), 47, 2-8.
16. Kyin, R., Hua, Y., Baybis, M., Scheithauer, B., Kolson, D., Uhlmann, E., Gutmann, D., and Crino, P.B. (2001) Differential cellular expression of neurotrophins in cortical tubers of the tuberous sclerosis complex. Am. J. Pathol., 159, 1541-1554.
17. Jay, V., Edwards, V., Musharbash, A., and Rutka, J.T. (1998) Cerebellar pathology in tuberous sclerosis. Ultrastruct. Pathol., 22, 331-339.
18. Kim, S.K., Wang, K.C., Cho, B.K., Jung, H.W., Lee, Y.J., Chung, Y.S., Lee, J.Y., Park, S.H. et al. (2001) Biological behavior and tumorigenesis of subependymal giant cell astrocytomas. J. Neurooncol., 52, 217-225.
19. Goh, S., Butler,W., and Thiele, E.A. (2004) Subependymal giant cell tumors in tuberous sclerosis complex. Neurology., 63, 1457-1461.
20. Takei, H., Adesina, A.M., and Powell, S.Z. (2009) Solitary subependymal giant cell astrocytoma incidentally found at autopsy in an elderly woman without tuberous sclerosis complex. Neuropathology., 29, 181-186.
21. Immunohistochemical characterization of subependymal giant cell astrocytomas. Acta Neuropathol., 91, 368-375.
22. Gyure, K.A. and Prayson, R.A. (1997) Subependymal giant cell astrocytoma: a clinicopathologic study with HMB45 and MIB-1 immunohistochemical analysis. Mod. Pathol., 10, 313-317.
23. Henske, E.P., Wessner, L.L., Golden, J., Scheithauer, B.W., Vortmeyer, A.O., Zhuang, Z., Klein-Szanto, A.J., and Kwiatkowski, D.J. (1997) Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors. Am. J. Pathol., 151, 1639-1647.
24. Sharma, M., Ralte, A., Arora, R., Santosh, V., Shankar, S.K., and Sarkar, C. (2004) Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins. Pathology., 36, 139-144.
25. Lee-Jones, L., Aligianis, I., Davies, P.A., Puga, A., Farndon, P.A., Stemmer-rachamimov, A., Ramesh, V., and Sampson, J.R. (2004) Sacrococcygeal chordomas in patients with tuberous sclerosis complex show somatic loss of TSC1 or TSC2. Genes Chromosomes Cancer, 41, 80-85.
26. Hirose, T., Scheithauer, B.W., Lopes, M.B., Gerber, H.A., Altermatt, H.J., Hukee, M.J., VandenBerg, S.R., and Charlesworth, J.C. (1995) Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron and microscopic study. Acta Neuropath., 90, 387-399.
27. Crino, P.B., Trojanowski, J.Q., Dichter, M.A., and Eberwine, J. (1996) Embryonic neuronal markers in tuberous sclerosis: single-cell molecular pathology. Proc.. Natl. Acad. Sci. USA, 26, 14152-14157.
28. Yamanouchi, H., Ho, M., Jay, V., and Becker, L.E. (1997) Giant cells in cortical tubers in tuberous sclerosis showing synaptophysin-immunoreactive halos. Brain Dev., 19, 21-24.
29. Talos, D.M., Kwiatkowski, D.J., Cordero, K., Black, P.M., and Jensen, F.E. (2008) Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers. Ann. Neurol., 63, 454-465.
30. Valencia, I., Legido, A., Yelin, K., Khurana, D., Kothare, S.V., and Katsetos, C.D. (2006) Anomalous inhibitory circuits in cortical tubers of human tuberous sclerosis complex associated with refractory epilepsy: aberrant expression of parvalbumin and calbindin-D28k in dysplastic cortex. J. Child Neurol., 21, 1058-1063.
31. Ess, K.C., Kamp, C.A., Tu, B.P., and Gutmann, D.H. (2005) Developmental origin of subependymal giant cell astrocytoma in tuberous sclerosis complex. Neurology., 26, 1446-1449.
32. Johnson, M.W., Miyata, H., and Vinters, H.V. (2002) Ezrin and moesin expression within the developing human cerebrum and tuberous sclerosisassociated cortical tubers. Acta Neuropathol., 104, 188-196.
33. Lee, A., Maldonado, M., Baybis, M., Walsh, C.A., Scheithauer, B., Yeung, R., Parent, J., Weiner, H.L., and Crino, P.B. (2003)Markers of cellular proliferation are expressed in cortical tubers. Ann. Neurol., 53, 668-673.
34. Mizuguchi, M., Yamanouchi, H., Becker, L.E., Itoh, M., and Takashima, S. (2002) Doublecortin immunoreactivity in giant cells of tuberous sclerosis and focal cortical dysplasia. Acta Neuropathol., 104, 418-424.
35. Hosoya, M., Naito, H., and Nihei, K. (1999) Neurological prognosis correlated with variations over time in the number of subependymal nodules in tuberous sclerosis. Brain Dev., 21, 544-547.
36. Ridler, K., Bullmore, E.T., De Vries, P.J., Suckling, J., Barker, G.J., Meara, S.J., Williams, S.C., and Bolton, P.F. (2001) Widespread anatomical abnormalities of grey and white matter structure in tuberous sclerosis. Psychol. Med., 31, 1437-1446.
37. Sugiura, C., Miyata, H., Ueda, M., Ohama, E., Vinters, H.V., and Ohno, K. (2008) Immunohistochemical expression of fibroblast growth factor (FGF)-2 in epilepsy-associated malformations of cortical development (MCDs). Neuropathology, 28, 372-381.
38. Marcotte, L. and Crino, P.B. (2006) The neurobiology of the tuberous sclerosis complex. Neuromolecular Med., 8, 531-546.
39. Huang, J. and Manning, B.D. (2008) The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem. J., 412, 179-190.
40. Baybis, M., Yu, J., Lee, A., Golden, J.A., Weiner, H., McKhann, I.I.G., Aronica, E., and Crino, P.B. (2004) Activation of the mTOR cascade distinguishes cortical tubers from focal cortical dysplasia. Ann. Neurol., 56, 478-487.
41. Miyata, H., Chiang, A.C., and Vinters, H.V. (2004) Insulin signaling pathways in cortical dysplasia and TSCtubers: tissue microarray analysis. Ann. Neurol., 56, 510-519.
42. Chan, J.A., Zhang, H., Roberts, P.S., Jozwiak, S., Wieslawa, G., Lewin-Kowalik, J., Kotulska, K., and Kwiatkowski, D.J. (2004) Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation. J. Neuropathol. Exp. Neurol., 63, 1236-1242.
43. Franz, D.N., Leonard, J., Tudor, C., Chuck, G., Care, M., Sethuraman, G., Dinopoulos, A., and Thomas, G. (2006) Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann. Neurol., 59, 490-498.
44. Henske, E.P., Wessner, L.L., Golden, J., Scheithauer, B.W., Vortmeyer, A.O., Zhuang, Z., Klein-Szanto, A.J., Kwiatkowski, D.J., and Yeung, R.S. (1997) Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors. Am. J. Pathol., 151, 1639-1647.
45. Sepp, T., Yates, J.R., and Green, A.J. (1996) Loss of heterozygosity in tuberous sclerosis hamartomas. J. Med. Genet., 33, 962-964.
46. Johnson, M.W., Emelin, J.K., Park, S.H., and Vinters, H.V. (1999) Co-localization of TSC1 and TSC2 gene products in tubers of patients with tuberous sclerosis. Brain Pathol., 9, 45-54.
47. Jozwiak, J. and Jozwiak, S. (2007) Giant cells: contradiction to two-hit model of tuber formation? Cell. Mol. Neurobiol., 27, 251-261.
48. Niida, Y., Stemmer-Rachamimov, A.O., Logrip, M., Tapon, D., Perez, R., Kwiatkowski, D.J., Sims, K., MacCollin, M. et al. (2001) Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions. Am. J. Hum. Genet., 69, 493-503.
49. Han, S., Santos, T.M., Puga, A., Roy, J., Thiele, E.A., McCollin, M., Stemmer-Rachamimov, A., and Ramesh, V. (2004) Phosphorylation of tuberin as a novel mechanism for somatic inactivation of the tuberous sclerosis complex proteins in brain lesions. Cancer Res., 64, 812-816.
50. Jozwiak, J.,Kotulska, K.,Grajkowskam, W., Jozwiak, S., Zalewski, W., Oldak, M., Lojek, M., Rainko, K. et al. (2007) Upregulation of the WNT pathway in tuberous sclerosis-associated subependymal giant cell astrocytomas. Brain Dev., 29, 273-280.
51. Onda, H., Crino, P.B., Zhang, H., Murphey, R.D., Rastelli, L., Gould-Rothberg, B.E., and Kwiatkowski, D.J. (2002) Tsc2 null murine neuroepithelial cells are a model for human tuber giant cells, and show activation of an mTOR pathway. Mol. Cell. Neurosci., 21, 561-574.
52. Wang, Y., Greenwood, J.S., Calcagnotto, M.E., Kirsch, H.E., Barbaro, N.M., and Baraban, S.C. (2007) Neocortical hyperexcitability in a human case of tuberous sclerosis complex and mice lacking neuronal expression of TSC1. Ann. Neurol., 61, 139-152.
53. Boer, K., Troost, D., Jansen, F., Nellist, M., van den Ouweland, A.M., Geurts, J.J., Spliet, W.G., Crino, P. et al. (2008) Clinicopathological and immunohistochemical findings in an autopsy case of tuberous sclerosis complex. Neuropathology., 28, 577-590.